Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

III. Medizinische Klinik und Poliklinik

Klinikum / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Weigmann, B; Lehr, HA; Rose-John, S et al.

The Transcription Factor NFATc2 Controls Apoptosis and Activation of T Cells by IL-6 in Colitis

CLINICAL IMMUNOLOGY. Bd. 135. 2010 S. S65-S66


Holgate, S; Buhl, R; Bousquet, J et al.

The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update (vol 103, pg 1098, 2009)

RESPIRATORY MEDICINE. Bd. 104. H. 6. 2010 S. 924-924


Hellmann, M; Hallek, M; Scharrer, I

Thrombotic-thrombocytopenic purpura

INTERNIST. Bd. 51. H. 9. 2010 S. 1136-+


Cornely, OA; Maertens, J; Bresnik, M et al.

Treatment outcome of invasive mould disease after sequential exposure to azoles and liposomal amphotericin B

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. Bd. 65. H. 1. 2010 S. 114-117


Cordonnier, C; Rovira, M; Maertens, J et al.

Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. Bd. 95. H. 10. 2010 S. 1762-1768


Kardos, P; Brüggenjürgen, B; Ezzat, N et al.

Wirtschaftlichkeit von BDP/Formoterol als fixe Kombination vs. Verordnung in zwei getrennten Inhalatoren

MMV - Fortschr Med. Bd. 152. 2010 S. 1-4


Janetzki, S; Britten, CM; Kalos, M et al.

"MIATA"-Minimal Information about T Cell Assays

IMMUNITY. Bd. 31. H. 4. 2009 S. 527-528


Becker, C; Kubach, J; Taube, C et al.

A humanized mouse model to study human regulatory T cells in vivo

EXPERIMENTAL DERMATOLOGY. Bd. 18. H. 3. 2009 S. 286-286


Maxeiner, JH; Karwot, R; Sauer, K et al.

A Key Regulatory Role of the Transcription Factor NFATc2 in Bronchial Adenocarcinoma via CD8(+) T Lymphocytes

CANCER RESEARCH. Bd. 69. H. 7. 2009 S. 3069-3076


Breitenbuecher, F; Markova, B; Kasper, S et al.

A novel molecular mechanism of primary resistance to FLT3-kinase inhibitors in AML

Blood. Bd. 113. H. 17. 2009 S. 4063-73